AQR Capital Management’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.1M Buy
808,285
+627,922
+348% +$2.57M ﹤0.01% 2068
2025
Q4
$669K Buy
180,363
+128,541
+248% +$1.1M ﹤0.01% 2770
2025
Q3
$732K Buy
+51,822
New +$808K ﹤0.01% 2611
2024
Q3
Sell
-9,495
Closed -$548K 2845
2024
Q2
$548K Sell
9,495
-3,250
-26% -$159K ﹤0.01% 2017
2024
Q1
$424K Buy
+12,745
New +$645K ﹤0.01% 2012

Other funds holding OM

AQR Capital Management's OM Position: Q1 2026 in Review

AQR Capital Management increased its Outset Medical (OM) stake by 348% in Q1 2026, buying an estimated $2.57M and bringing the position to 808,285 shares worth $3.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2068.

AQR Capital Management first reported a position in OM in Q1 2024 and has held it in 5 quarters since. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • AQR Capital Management held 808,285 shares of Outset Medical worth $3.1M as of Q1 2026.
  • AQR Capital Management bought 627,922 Outset Medical shares in Q1 2026, an estimated $2.57M.
  • Outset Medical made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #2068 holding.
  • AQR Capital Management first reported a position in Outset Medical in Q1 2024 and has held it in 5 quarters since.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.